Thomas Madden
Chief Executive Officer at Acuitas Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stephen Aselage | M | 73 |
Acuitas Therapeutics, Inc.
 Acuitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Acuitas Therapeutics is a private biotechnology company based in Vancouver, Canada that specializes in developing delivery systems for nucleic acid therapeutics based on lipid nanoparticles. The Canadian company partners with pharmaceutical and biotechnology companies, academic institutes, and non-governmental organizations to advance nucleic acid therapeutics into clinical trials and the marketplace. Acuitas Therapeutics has agreements in place with several partners to use its proprietary lipid nanotechnology in the development of COVID-19 vaccines, including Pfizer/BioNTech for Comirnaty®. The CEO of the company is Thomas Madden. | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 1 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Thomas Madden
- Personal Network
